ArticleClinical and experimental nephrology2026
Albuminuria and hematologic profiles across eGFR categories in U.S. adults: NHANES 2001-2018 with detailed iron-biomarker analysis.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlbuminuria and estimated glomerular filtration rate (eGFR) are complementary dimensions of kidney disease, but the hematologic phenotype of albuminuria beyond reduced filtration is incompletely defined.
methodsWe analyzed adults aged ≥20 years in nine National Health and Nutrition Examination Survey (NHANES) cycles (2001-2018). The primary outcome was hemoglobin; secondary outcomes were anemia, red-cell indices, and serum iron. UACR was modeled per doubling and by KDIGO A1-A3 categories using survey-weighted models adjusted for eGFR and clinical covariates. Ferritin, transferrin saturation (TSAT), iron-binding measures, and soluble transferrin receptor (sTfR) were examined in 2017-2018.
resultsAmong 42,634 participants, 40,705 entered the primary model. The prespecified primary hypothesis was not supported: UACR was not significantly associated with mean hemoglobin (beta per doubling, -0.008 g/dL; 95% confidence interval [CI], -0.020 to 0.004). UACR was associated with secondary anemia (odds ratio [OR] per doubling, 1.112; 95% CI, 1.078-1.147; A2 vs A1, OR 1.332; A3 vs A1, OR 1.855). RDW, MCV, MCH, and serum iron differences were small; sTfR showed a small exploratory association. Ferritin- and TSAT-based phenotypes were not significantly associated with UACR.
conclusionsThe prespecified mean-hemoglobin hypothesis was not supported. Higher UACR was associated with threshold-defined anemia as a secondary outcome, while small red-cell and iron-marker differences did not establish conventional absolute iron deficiency or imply changes in anemia management.
Indexed as
Identifiers
42859377What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.